2000
DOI: 10.1111/j.1572-0241.2000.01846.x
|View full text |Cite
|
Sign up to set email alerts
|

Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease

Abstract: The incidence of pregnancy-related complications was significantly increased when the fathers used 6-MP within 3 months of conception.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
44
0
6

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 142 publications
(52 citation statements)
references
References 20 publications
2
44
0
6
Order By: Relevance
“…4,5 Recently, concerns have been raised regarding the risk of pregnancy-related complications in the offspring when the father is treated with mercaptopurine before conception. [6][7][8][9][10][11] The main concern is based on data from a cohort study reporting an increased risk of congenital abnormalities in the offspring when the fathers had taken mercaptopurine before conception (two cases of congenital abnormality in 50 exposed pregnancies and no cases in 90 controls). 6 Thus, the safety of mercaptopurine in the area of reproduction has been brought into question, and attention has been drawn to a potentially teratogenic effect.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…4,5 Recently, concerns have been raised regarding the risk of pregnancy-related complications in the offspring when the father is treated with mercaptopurine before conception. [6][7][8][9][10][11] The main concern is based on data from a cohort study reporting an increased risk of congenital abnormalities in the offspring when the fathers had taken mercaptopurine before conception (two cases of congenital abnormality in 50 exposed pregnancies and no cases in 90 controls). 6 Thus, the safety of mercaptopurine in the area of reproduction has been brought into question, and attention has been drawn to a potentially teratogenic effect.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8][9][10][11] The main concern is based on data from a cohort study reporting an increased risk of congenital abnormalities in the offspring when the fathers had taken mercaptopurine before conception (two cases of congenital abnormality in 50 exposed pregnancies and no cases in 90 controls). 6 Thus, the safety of mercaptopurine in the area of reproduction has been brought into question, and attention has been drawn to a potentially teratogenic effect. 6,7,9,10 Pregnancy outcomes depend on both maternal and paternal factors, and the hypothesis of an increased risk of birth defects associated with paternal drug exposure is not new.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…38 In their study, 57 men who fathered 140 pregnancies and their wives were interviewed. Pregnancies were divided into three groups: (1) 13 pregnancies where the father had taken 6-MP within three months prior to conception; (2) 37 where the father had discontinued 6-MP use three or more months before conception, and (3) 90 pregnancies where the father had never taken 6-MP prior to conception.…”
Section: Immunomodulatorsmentioning
confidence: 99%
“…Wenn auch we gen ei ner klei nen Fall zahl kontro vers dis ku tiert, gibt es Hin wei se da für, dass die Schwan ger schafts kom pli ka ti onsra te (Ab or te und Fehl bil dun gen) dann erhöht ist, wenn Män ner 6-Mer cap to pu rin bis in ner halb von 3 Mo na ten vor der Konzep ti on ein ge nom men hat ten. Hier sind sicher wei ter hin Stu di en not wen dig, um einen Zu sam men hang nach wei sen oder ausschlie ßen zu kön nen [32].…”
Section: Aus Wir Kun Gen Auf Die Fer Ti LI Tätunclassified